RIZATRIPTAN Benzoate
- Product NDC
- 51991-363
- 11-digit product format
- 519910363
- Labeler code
- 51991
- Product ID
- 51991-363_24ffdbe7-4f42-4277-942a-9edd765df282
- Type
- HUMAN PRESCRIPTION DRUG
- Nonproprietary name
- RIZATRIPTAN Benzoate
- Dosage form
- TABLET, ORALLY DISINTEGRATING
- Route
- ORAL
- Labeler
- Breckenridge Pharmaceutical, Inc.
- Application
- ANDA203478
- Marketing category
- ANDA
- Marketing start
- 2013-07-01
- Marketing end
- 0000-00-00
- Substance
- RIZATRIPTAN BENZOATE
- Active strength
- 10 mg/1
- Pharmacologic classes
- Serotonin 1b Receptor Agonists [MoA],Serotonin 1d Receptor Agonists [MoA],Serotonin-1b and Serotonin-1d Receptor Agonist [EPC]
- NDC exclude flag
- No
- Listing certified through
- 2021-12-31
- Current FDA listing
- Historical FDA.report record
DailyMed Product Concepts#
DailyMed Socrata Ingredients#
Ingredient, Type, UNII table| Ingredient | Type | UNII | DailyMed label | SPL version | Uploaded |
|---|
| RIZATRIPTAN BENZOATE | ACTIVE INGREDIENT | WR978S7QHH | RIZATRIPTAN BENZOATE (RIZATRIPTAN BENZOATE ) TABLET, ORALLY DISINTEGRATING [BRECKENRIDGE PHARMACEUTICAL, INC.] | 4 | |
| RIZATRIPTAN | ACTIVE MOIETY | 51086HBW8G | RIZATRIPTAN BENZOATE (RIZATRIPTAN BENZOATE ) TABLET, ORALLY DISINTEGRATING [BRECKENRIDGE PHARMACEUTICAL, INC.] | 4 | |
| ASPARTAME | INACTIVE INGREDIENT | Z0H242BBR1 | RIZATRIPTAN BENZOATE (RIZATRIPTAN BENZOATE ) TABLET, ORALLY DISINTEGRATING [BRECKENRIDGE PHARMACEUTICAL, INC.] | 4 | |
| CELLULOSE, MICROCRYSTALLINE | INACTIVE INGREDIENT | OP1R32D61U | RIZATRIPTAN BENZOATE (RIZATRIPTAN BENZOATE ) TABLET, ORALLY DISINTEGRATING [BRECKENRIDGE PHARMACEUTICAL, INC.] | 4 | |
| CROSCARMELLOSE SODIUM | INACTIVE INGREDIENT | M28OL1HH48 | RIZATRIPTAN BENZOATE (RIZATRIPTAN BENZOATE ) TABLET, ORALLY DISINTEGRATING [BRECKENRIDGE PHARMACEUTICAL, INC.] | 4 | |
| CROSPOVIDONE | INACTIVE INGREDIENT | 68401960MK | RIZATRIPTAN BENZOATE (RIZATRIPTAN BENZOATE ) TABLET, ORALLY DISINTEGRATING [BRECKENRIDGE PHARMACEUTICAL, INC.] | 4 | |
| GLYCINE | INACTIVE INGREDIENT | TE7660XO1C | RIZATRIPTAN BENZOATE (RIZATRIPTAN BENZOATE ) TABLET, ORALLY DISINTEGRATING [BRECKENRIDGE PHARMACEUTICAL, INC.] | 4 | |
| MAGNESIUM STEARATE | INACTIVE INGREDIENT | 70097M6I30 | RIZATRIPTAN BENZOATE (RIZATRIPTAN BENZOATE ) TABLET, ORALLY DISINTEGRATING [BRECKENRIDGE PHARMACEUTICAL, INC.] | 4 | |
| MANNITOL | INACTIVE INGREDIENT | 3OWL53L36A | RIZATRIPTAN BENZOATE (RIZATRIPTAN BENZOATE ) TABLET, ORALLY DISINTEGRATING [BRECKENRIDGE PHARMACEUTICAL, INC.] | 4 | |
| MONOSODIUM CITRATE | INACTIVE INGREDIENT | 68538UP9SE | RIZATRIPTAN BENZOATE (RIZATRIPTAN BENZOATE ) TABLET, ORALLY DISINTEGRATING [BRECKENRIDGE PHARMACEUTICAL, INC.] | 4 | |
| PEPPERMINT | INACTIVE INGREDIENT | V95R5KMY2B | RIZATRIPTAN BENZOATE (RIZATRIPTAN BENZOATE ) TABLET, ORALLY DISINTEGRATING [BRECKENRIDGE PHARMACEUTICAL, INC.] | 4 | |
| SODIUM CHLORIDE | INACTIVE INGREDIENT | 451W47IQ8X | RIZATRIPTAN BENZOATE (RIZATRIPTAN BENZOATE ) TABLET, ORALLY DISINTEGRATING [BRECKENRIDGE PHARMACEUTICAL, INC.] | 4 | |
DailyMed Dashboard NDC Coverage#
NDC, Dashboard title, SPL version table| NDC | Dashboard title | SPL version | Validation | Dashboard ZIP |
|---|
| 51991-363 | RIZATRIPTAN BENZOATE TABLET, ORALLY DISINTEGRATING [BRECKENRIDGE PHARMACEUTICAL, INC.] | 10 | Legacy NDC | 20240327_cd03ee57-0fb8-4ddf-88e8-b1f953a593f8.zip |
Packages#
Package NDC, 11-digit format, Description table| Package NDC | 11-digit format | Description | Units | Marketing start | Marketing end | Sample | Exclude flag | Status |
|---|
| 51991-363-78 | 51991036378 | 3 BLISTER PACK in 1 CARTON (51991-363-78) > 6 TABLET, ORALLY DISINTEGRATING in 1 BLISTER PACK (51991-363-99) | 3 blister pack | 2013-07-01 | 0000-00-00 | No | No | Current |